Rediscovering a language of healing that doesn’t require ‘cure’
By Lee D. Cooper,
STAT News
| 03. 02. 2022
"Doctor Patient and Xray" by andyde is marked with CC BY-NC 2.0.
I am a biotech investor and entrepreneur. But more central to my worldview is that I am someone who lives with a rare genetic disease. This has sensitized me to the flippant ways that excited scientists and entrepreneurs toss around notions of “cures,” especially when genomic manipulation is involved.
No matter what work is in front of me, I see it through the lens of life with a disease-causing typo in the six billion DNA letters that make up the story of my genome. I have a C (for cytosine) where there should be G (for guanine), an error that sits within a gene that is essential for building the heart’s electrical current. Such a defect can lead to potentially lethal irregularities in my heart’s rhythm. The condition is called long QT syndrome.
A few months ago, I felt all sorts of emotions welling up when I came upon an article in a top journal announcing a new gene-editing method for correcting an erroneous G...
Related Articles
By Katie Hunt, CNN | 07.30.2025
Scientists are exploring ways to mimic the origins of human life without two fundamental components: sperm and egg.
They are coaxing clusters of stem cells – programmable cells that can transform into many different specialized cell types – to form...
By Ewen Callaway, Nature | 08.04.2025
For months, researchers in a laboratory in Dallas, Texas, worked in secrecy, culturing grey-wolf blood cells and altering the DNA within. The scientists then plucked nuclei from these gene-edited cells and injected them into egg cells from a domestic dog ...
By Kristel Tjandra, Genetic Engineering & Biotechnology News | 07.30.2025
CRISPR has taken the bioengineering world by storm since its first introduction. From treating sickle cell diseases to creating disease-resistant crops, the technology continues to boast success on various fronts. But getting CRISPR experiments right in the lab isn’t simple...
By Arthur Caplan and James Tabery, Scientific American | 07.28.2025
An understandable ethics outcry greeted the June announcement of a software platform that offers aspiring parents “genetic optimization” of their embryos. Touted by Nucleus Genomics’ CEO Kian Sadeghi, the $5,999 service, dubbed “Nucleus Embryo,” promised optimization of...